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Mycobacterium leprae infects skin and peripheral nerves causing deformities and disability.
The  M. leprae bacterium binds to ErbB2 on the Schwann cell surface causing demyelination
and favoring spread of the bacilli and causing nerve injury. Polymorphisms at the ERBB2
gene were previously investigated as genetic risk factors for leprosy in two Brazilian popu-
lations but with inconsistent results. Herein we extend the analysis of ERBB2 variants to a
third geographically distinct population in Brazil. Our results show that there is no asso-
ciation between the genotyped SNPs and the disease (p > 0.05) in this population. A geneGene analysis
Leprosy
set  or pathway analysis under the genomic region of ERBB2 will be necessary to clarify its
regulation under M. leprae stimulus.
© 2015 Elsevier Editora Ltda. All rights reserved.Leprosy is a chronic infectious disease caused by Mycobac-
terium leprae,  and inﬂuenced by genetic and environmental
factors. This infection has a broad clinical and immunological
spectrum that causes high morbidity rates, with a major
impact on public health. Although leprosy prevalence has
been extensively reduced after the introduction of multidrug
therapy and vaccination with BCG1 more  than 200,000 new
cases are reported annually according to World Health
Organization.2 The spectrum of clinical manifestations is
illustrated by two polar forms, tuberculoid and lepromatous
3leprosy, and various intermediate or borderline forms.
Peripheral nerve damage, the most serious complication of
leprosy, is associated with immunological and inﬂammatory
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that can extend for years after cure of the infection. The
ERBB2 gene lies on chromosome 17q11-q21, and encodes
an important class of receptor tyrosine kinases involved in
transmission of biochemical signals.4 The binding of M.  leprae
to myelinated Schwann cells through ligation to the ErbB2
receptor results in Schwann cell demyelination and increases
the population of de-differentiated Schwann cells through
the Erk1/2 signaling pathway.5 This creates an environment
that favors M. leprae proliferation and leads to nerve damage.llowing persons: Jamile Leão Rêgo, Joyce Moura Oliveira, Nadja de
me Shibuya, Lídia Maria Machado, Paulo Roberto Lima Machado
Recent data have shown that polymorphisms in the ERBB2
gene were associated with leprosy development in families
from Pará State, but not in a population from the state of
b r a z j i n f e c t d i s . 2 0 1 5;1 9(2):206–208 207
Table 1 – Characteristics of case–control sample from the
population of Bahia, Brazil.
(A) Patients characteristics
n Individuals Mean age (years) ± SDa Male:female
Cases 362 42.32 ± 12.88 199:163
Controls 368 34.80 ± 10.24 258:110
(B) Clinical characteristics of the cases cohort
Clinical phenotype n
Tuberculoid (TT) 44
Borderline TT (BT) 48
Borderline (BB) 38
Borderline lepromatous (BL) 40
Lepromatous (LL) 124
Unclassiﬁed leprosy 63
Other leprosy clinical forms 5
RR 80
ENL 84
Totalb 362
Note.
a SD, standard deviation; RR reversal reactions; ENL, erythema
nodosum leprosum.
b RR and ENL patients are also classiﬁed under leprosy clinical
R
g
t
b
a
s
S
r
d
i
r
a
s
5
1
a
p
r
(
Table 3 – Results of logistic regression analyses for the
genotyped ERBB2 polymorphisms.
ERBB2 alleles Global test OR (95% CI) p-Value
2 df 1 df
rs2517955 (T vs. C) 0.239 0.227 1.14 (0.92–1.41) 0.228
rs2517956 (A vs. G) 0.051 0.364 1.10 (0.88–1.37) 0.365
rs1810132 (T vs. C) 0.179 0.406 1.10 (0.87–1.40) 0.407
rs2952156 (G vs. A) 0.098 0.368 1.10 (0.88–1.38) 0.369
rs1136201 (A vs. G) 0.660 0.550 1.10 (0.79–1.54) 0.550
Note.  The 2 df test represents the genotype-wise test, and the 1 dfspectrum.
io Grande do Norte in Brazil.6 Herein we investigate a
eographically distinct population from Northeastern Brazil
o further evaluate the role of this gene in leprosy suscepti-
ility. The state of Bahia is considered of medium endemicity,
ccording to the parameter of prevalence.7 Three hundred and
ixty-two leprosy cases were selected at the Hospitals Edgard
antos and Dom Rodrigo de Menezes. Both are considered
eference centers for treatment of the disease with patients
iagnosed according to the guidelines of the Brazilian Min-
stry of Health. Additionally, 368 local blood bank donors were
ecruited as controls. Informed consent was obtained from
ll participants. Approval for the use of the samples in this
tudy was obtained from the Federal University of Bahia (CEP-
0/2010) and the Brazilian National Ethical Committee (CONEP
1019). Detailed complementary data about cases and controls
re described in Table 1. Five single nucleotide polymor-
hisms (SNPs) (rs2517955, rs2517956, rs1810132, rs2952156,
s1136201) were genotyped by TaqMan RT-PCR technology
Applied Biosystems®) using Pre-designed genotyping assays.
Table 2 – Details of ERBB2 single nucleotide polymorphisms (SN
SNP rs# Location (Build Hg19) Cohorts genotyped Minor allele 
rs2517955 37843931 RN/Bahia C 
rs2517956a 37844109 Pará/RN/Bahia G 
rs1810132 37866255 RN/Bahia C 
rs2952156a 37877085 Pará/RN/Bahia A 
rs1136201a 37879838 RN/Bahia G 
Adapted from Araújo et al.6
Note.  Cohorts are from Pará, RN and Bahia states in northeastern Brazil.
a SNPs associated with leprosy in Pará.test represents the allele-wise test. CI, conﬁdence interval; OR, odds
ratio. The OR and p-values refer to 1 df tests.
Table 2 describes characteristics of the SNPs used in this study
and compares the minor allele frequencies between the three
Northeastern populations. Tests for Hardy-Weinberg equilib-
rium and unconditional logistic regression analysis were done
using STATA 8.2 with the freely available GenAssoc package
(http://www-gene.cimr.cam.ac.uk/clayton/software/stata/) to
determine allele-wise (1 df test) and genotype-wise (2 df test)
associations between ERBB2 SNPs and leprosy. Our analysis
did not show any signiﬁcant association between the ﬁve
genotyped markers and leprosy per se (p > 0.05), as presented
in Table 3. Nor were there any associations between ERBB2
polymorphisms and either lepromatous or tuberculoid forms
of disease (data not shown).
The data showed here support previous observations of
a lack of association between ERBB2 genetic variants and
susceptibility to leprosy per se in a similar population-
based case-control data set from Rio Grande do Norte.6 Our
population-based study in Bahia and that in Rio Grande do
Norte had larger sample sizes than the smaller family-based
study in Pará, suggesting that the association observed in
the latter population may represent a false positive result.
However, Araújo et al.6 draw attention to the fact that ERBB2
lies under a linkage peak8,9 for leprosy observed in the same
large pedigrees employed for the study in Pará State. The
region of the linkage peak at chromosome 17q11-q22 is a gene
dense region of potential immunological candidate genes con-
tributing to leprosy susceptibility.8,9 This raises the possibility
that variants at ERBB2 might contribute to larger chromo-
some haplotypes transmitted to affected individuals in these
Pará families. Further investigation is necessary to clarify if
ERBB2 contributes genetically and/or functionally to leprosy
Ps) genotyped in the three populations.
Minor allele frequency (Pará/RN/Bahia) Position/function
0.49/0.41 Upstream region
0.38/0.38/0.42 Upstream region
0.39/0.40 Intronic
0.38/0.38/0.38 Intronic
0.15/0.12 Coding, non-syn (I655V)
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susceptibility in these families. Recent data shows that M.  lep-
rae hijacks the plasticity of adult Schwann cells, to reprogram
infected cells to a progenitor/stem cell-like cells as a bacte-
rial strategy to spread infection to other tissues.10 In addition,
reprogrammed cells can attract macrophages, providing evi-
dence for a functional role of innate immune response
genes during reprogramming.11 Finally, although gene analy-
ses based on a single data type, such as gene expression data or
SNP data, have successfully revealed altered cellular processes
associated with different complex diseases12–15 it is also
known that single variant or single gene analyses generally
account for only a small proportion of the phenotypic varia-
tion in complex traits. In this sense, we  have to consider that
ERBB2 is located within a genetic locus that contains a number
of genes directly involved in the immune response and patho-
genesis of infectious diseases. A well-powered genome-wide
association study would be needed to determine a role for
ERBB2 relative to other genes that have been shown to achieve
genome-wide signiﬁcance in other populations.
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